ACAAI releases guidance related to risk of allergic reactions to Pfizer-BioNTech COVID-19 vaccine

[Mary Wilson]

Reviewed by Emily Henderson, B.Sc.
Dec 14 2020


With the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine by the FDA on December 11, 2020, and distribution beginning today, the American College of Allergy, Asthma and Immunology COVID-19 Vaccine Task Force recommends the following guidance related to risk of an allergic reaction on vaccination for those who receive the vaccine. These recommendations are based on best knowledge to date but could change at any time, pending new information and further guidance from the FDA or CDC.

https://www.news-medical.net/news/2...ions-to-Pfizer-BioNTech-COVID-19-vaccine.aspx

 

[Mary Wilson]

A guide to who can safely get the Pfizer/BioNTech Covid-19 vaccine

By HELEN BRANSWELL
DECEMBER 14, 2020

With the first doses of Covid-19 vaccine being administered across the United States, questions abound about who can safely get them.

Expect answers to those questions to evolve as the vaccines go into broader use. But here’s what is known so far, and what experts at or advising the Centers for Disease Control and Prevention recommend regarding their use at this point.

Pregnant people

The Covid vaccine developed by Pfizer and its partner, BioNTech, hasn’t yet been tested in pregnant people — in fact none of the vaccines in development have been.
...
https://www.statnews.com/2020/12/14...ely-get-the-pfizer-biontech-covid-19-vaccine/